Newmain Human Dermatech Cuts MS Bio Stake to 8.22%
Newmain Human Dermatech New Technology Investment Association sold 577,833 MS Bio shares on the market on Oct. 22 and 26, 2026.
Related stories
AI Stocks Fall After Alphabet Earnings Disappoint
Technology stocks slid globally after earnings from major U.S. and Asian tech companies revived concerns about monetizing artificial intelligence. Nasdaq futures fell 1.1%.
M impact | EQUITY | Oct 29, 2026, 09:55 AM UTC
TBEA Reports Third-Quarter Net Profit Down 57% Year Over Year
TBEA said third-quarter net profit fell 57% year over year.
M impact | EQUITY | Oct 29, 2026, 09:54 AM UTC
India's Nifty 50 Indicative Level Up 0.29%
The indicative level pared pre-auction gains of 1.07%.
M impact | EQUITY | Oct 29, 2026, 09:50 AM UTC
Renault Q3 revenue beats forecast as EV demand lifts shares
Renault said third-quarter revenue rose 1.4% at constant exchange rates.
M impact | EQUITY | Oct 29, 2026, 09:50 AM UTC
Ambuja Cements Reports Quarterly Profit Drop as Fuel, Freight Costs Rise
M impact | EQUITY | Oct 29, 2026, 09:50 AM UTC
TBEA Says Q3 Net Profit Fell 57% Year Over Year
TBEA said third-quarter net profit declined 57% year over year.
M impact | EQUITY | Oct 29, 2026, 09:49 AM UTC